Adding dapagliflozin to diabetes regimen may help reduce blood sugar, weight among patients
SAN DIEGO — Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.
AstraZeneca and Bristol-Myers Squibb announced results of an extension to a phase-3 study in which patients took either metformin with dapagliflozin or metformin with a placebo over nearly two years. The study found that patients in the treatment group reduced blood sugar by between 0.48% and 0.78%, while those taking metformin with placebo saw increases of 0.02%.
Patients in the dapagliflozin group also achieved better weight reduction than those in the placebo group.
Results of the study were presented at the 71st scientific sessions of the American Diabetes Association.
No comments found
Sam’s Club to offer free children’s health, ID screenings
BENTONVILLE, Ark. — Sam’s Club is helping parents prepare for the back-to-school season by offering free children’s health and ID screenings at stores nationwide on July 9.
From 11 a.m. to 3 p.m., shoppers can take advantage of the screenings, which will include blood pressure, body mass index and vision checks, as well as fingerprint kits and DNA swabs. The tests, valued at $100, will be conducted by certified technicians from Carmen Ingle and Associates. Additionally, fingerprint kits will be administered by the in-club technician, while the DNA swab kit can be administered in Sam’s Club or taken home by a parent.
The in-club children’s health and ID screenings are sponsored by Band-Aid, Clif Kid, Dial, G2, L’il Critters, Neosporin and Neo To Go! The brands will provide samples on site, Sam’s Club said.
"Summer is the perfect time to take advantage of children’s extra free time by scheduling health checkups," Sam’s Club SVP Jill Turner-Mitchael said. "As the summer continues and kids are out playing, we know that safety is also important to parents, so Sam’s Club is offering a special joint health and safety screening to help protect children in the event they are ever lost. At Sam’s Club, we are proud to provide our members with quality health solutions for the entire family."
No comments found
Consumer Reports: Rx labels miss mark on providing important safety information
YONKERS, N.Y. — Important safety information often is missing from drug labels, while some pharmacies don’t include medication guides required by the federal government, according to a new investigation by Consumer Reports.
Consumer Reports Health sent members of its staff on an investigative “spot check” to Costco, CVS, Target, Walgreens and Walmart stores in Yonkers, N.Y., to fill prescriptions for the common blood-thinning drug warfarin. While cautioning that their findings were not representative of the retailers at the national level, the staffers found that four of the pharmacies didn’t provide medication guides. The patient materials they did provide were different from the ones approved by the Food and Drug Administration and also contained conflicting warnings about using alcohol with the drug; while the FDA recommends that patients not drink at all while using warfarin, medication guides from Costco and CVS advised patients to “limit or avoid” alcohol.
The number of warnings on the bottles differed as well. The prescriptions filled at Target and Walgreens each had four warnings printed directly on the labels, while CVS had three and Costco had two warning stickers. At first, Walmart didn’t have any warnings, but prescriptions picked up on a second trip to the store and during a visit to another store each included three warning stickers.
Consumer Reports Health prescription drug editor Lisa Gill blamed a lack of unified, national standards for the problem. For example, while foods and over-the-counter drugs must carry “Nutrition Facts” and “Drug Facts” labels that are uniform throughout the country, there is no equivalent for prescription drugs. In addition, state boards of pharmacy are in charge of monitoring the content of drug labels, and it’s up to the pharmacist to decide whether the bottles should include warnings.
“It’s my opinion that the inconsistencies and omissions on drug labels really cry out for uniformity and federal oversight,” Consumer Reports Health chief medical adviser Marvin Lipman said. “FDA regulation can solve this.”
But Target’s bottle design did receive some praise in the report; Consumer Reports pointed out that the mass-merchandise chain’s triangular containers provide enough space for detailed instructions and multiple warnings, while drug information is included in large type.
I don't know what warning labels were included or excluded from the bottle, but quantity is not always quality. I have found that if you put too many labels on a bottle, they are ignored. Appropriate use of important auxiliary labels along with good counseling will best serve the patient. I think this study by consumer reports was poorly concieved and does not really add any value. There is no mention of pharmacist counseling or the offer to counsel. Does Consumer Report feel that a few labels on a bottle is all that is necessary for a consumer to understand the drug they are taking?